Literature DB >> 20345125

Synthesis of a novel alpha-galactosyl ceramide haptenated-lipid antigen, a useful tool in demonstrating the involvement of iNKT cells in the production of antilipid antibodies.

Natacha Veerapen1, Elizabeth A Leadbetter, Michael B Brenner, Liam R Cox, Gurdyal S Besra.   

Abstract

A new haptenated derivative of alpha-galactosyl ceramide (alpha-GalCer) has been synthesized to assist in the study of the mechanism of T cell help for the production of B cell antibodies. Our synthetic route provides access to an amine intermediate which can easily be extended to generate an array of compounds, useful in various ongoing studies. Herein, we also describe the biological evaluation of the nitrophenyl (NP) haptenated alpha-GalCer and demonstrate its importance in such mechanistic studies. For instance, in vitro studies showed that NP-alpha-GalCer stimulates both T and B cell proliferation while in vivo studies in immunized mice showed the production of IgG anti-NP antibodies after exposure to NP-alpha-GalCer. The interpretation of these results helps toward a better understanding of T cell help for the production of antibodies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345125      PMCID: PMC3833054          DOI: 10.1021/bc9005255

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  23 in total

Review 1.  Autoreactivity by design: innate B and T lymphocytes.

Authors:  A Bendelac; M Bonneville; J F Kearney
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

2.  Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.

Authors:  Masakazu Fujio; Douglass Wu; Raquel Garcia-Navarro; David D Ho; Moriya Tsuji; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2006-07-19       Impact factor: 15.419

3.  Strategy for affinity maturation of an antibody with high evolvability to (4-hydroxy-3-nitrophenyl) acetyl hapten.

Authors:  Koji Furukawa; Takeyuki Shimizu; Akikazu Murakami; Ryo Kono; Masatoshi Nakagawa; Takuma Sagawa; Ichiro Yamato; Takachika Azuma
Journal:  Mol Immunol       Date:  2006-11-21       Impact factor: 4.407

Review 4.  Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.

Authors:  S Hong; D C Scherer; N Singh; S K Mendiratta; I Serizawa; Y Koezuka; L Van Kaer
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

Review 5.  CD1d ligands: the good, the bad, and the ugly.

Authors:  Randy R Brutkiewicz
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

6.  Characterization of (4-hydroxy-3-nitrophenyl)acetyl (NP)-specific germinal center B cells and antigen-binding B220- cells after primary NP challenge in mice.

Authors:  Kristy L Wolniak; Randolph J Noelle; Thomas J Waldschmidt
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

Review 7.  Mouse CD1-specific NK1 T cells: development, specificity, and function.

Authors:  A Bendelac; M N Rivera; S H Park; J H Roark
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

8.  A stable, commercially available sulfenyl chloride for the activation of thioglycosides in conjunction with silver trifluoromethanesulfonate.

Authors:  David Crich; Feng Cai; Fan Yang
Journal:  Carbohydr Res       Date:  2008-03-10       Impact factor: 2.104

9.  Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells.

Authors:  Nadine Y Crowe; Adam P Uldrich; Konstantinos Kyparissoudis; Kirsten J L Hammond; Yoshihiro Hayakawa; Stephané Sidobre; Rachael Keating; Mitchell Kronenberg; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

10.  B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo.

Authors:  Patricia Barral; Julia Eckl-Dorna; Naomi E Harwood; Carmela De Santo; Mariolina Salio; Petr Illarionov; Gurdyal S Besra; Vincenzo Cerundolo; Facundo D Batista
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

View more
  3 in total

1.  Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.

Authors:  Lisa M Fox; Jennifer Miksanek; Nathan A May; Louise Scharf; Jennifer L Lockridge; Natacha Veerapen; Gurdyal S Besra; Erin J Adams; Amy W Hudson; Jenny E Gumperz
Journal:  Cancer Immun       Date:  2013-05-10

2.  Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues.

Authors:  Peter J Jervis; Marie Moulis; John-Paul Jukes; Hemza Ghadbane; Liam R Cox; Vincenzo Cerundolo; Gurdyal S Besra
Journal:  Carbohydr Res       Date:  2012-03-07       Impact factor: 2.104

Review 3.  Stimulation of natural killer T cells by glycolipids.

Authors:  Brian L Anderson; Luc Teyton; Albert Bendelac; Paul B Savage
Journal:  Molecules       Date:  2013-12-16       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.